Hasil Pencarian (1)
small molecule | CAS: 1421373-65-0
Osimertinib is an oral, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals.[A7926,L43453] Its use is indicated for the treatment of metastatic non-small cell lung cancer (NSCL…
Kategori:
Acids, AcyclicAcrylatesAmides
+29
Target Protein:
Epidermal growth factor receptor
Waktu ParuhThe population esti…
Vol. DistribusiThe mean volume of …
KlirensOral clearance is 1…
Genetik
-